Aztreonam

Aztreonam

5.4 Moderate risk

Aztreonam & Hepatic cytolysis

100.0%

of users reported Hepatic cytolysis

100.0%

also reported Severe reaction

70.0%

are women

Most common medical consequences

Severe reaction
100.0%

Have you experienced any negative side effects from this medication?

Aztreonam: general information

Most common side effects (1)

Most commonly affected ages

30 - 39 years
43.2%
40 - 49 years
<0.1%
50 - 59 years
29.7%
60 - 69 years
<0.1%
70 - 79 years
<0.1%
80 - 89 years
27.0%
On this page
Aztreonam & Hepatic cytolysis
Aztreonam: general information